Fatigue : You might feel more tired or sluggish as your body adjusts to functioning without the assistance of semaglutide
FDA-approved medications in this class include: Clinical trials have shown patients losing 1521% of body weight over 72 weeks when using these medications alongside diet and exercise

GLP-1 RAs reduce major cardiovascular events by 14% through multiple mechanisms beyond glucose control, including anti-inflammatory effects and blood pressure reduction SELECT trial proved cardiovascular benefits extend to non-diabetic patients with obesity, showing 20% MACE reduction in those without diabetes Semaglutide, liraglutide, and dulaglutide demonstrate the strongest cardiovascular protection, with proven benefits in large outcome trials These agents provide specific benefits for heart failure with preserved ejection fraction and kidney protection, reducing albuminuria by 24% Current guidelines strongly recommend GLP-1 RAs for patients with established cardiovascular disease, regardless of diabetes status or HbA1c levels The evidence positions GLP-1 receptor agonists as fundamental cardiovascular medications rather than merely diabetes drugs with heart benefits
There is no current evidence that retatrutide reduces cardiovascular events
Great thing I have lost weight as well So wonderful for energy and weight loss
Skinless chicken breast is lean and generally much easier to digest